Early identification and standardization of clinical trials are essential for improving prognosis. Diagnosis of this disease requires a combination of clinical trials, imaging inspections, laboratory tests and pathological biopsies. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs.
Individualised development of treatment programs for treatment and management of adult refsum disease typically includes drug therapy, rehabilitation, and regular follow-up visits. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many genetic metabolic diseases that were previously difficult to treat have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions, adapting to timely schemes according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of adult refsum disease. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.